Metropolitan Life Insurance CO Opti Nose, Inc. Transaction History

Metropolitan Life Insurance CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.17 - $1.94 $4,715 - $7,818	4,030 New	4,030 $5,000
Q3 2020 Nov 13, 2020	SELL	$3.69 - $7.09 $40,881 - $78,550	-11,079 Closed	0 $0
Q2 2020 Jun 26, 2023	BUY	$3.58 - $7.44 $39,662 - $82,427	11,079 New	11,079 $82,000
Q2 2020 Mar 30, 2023	BUY	$3.58 - $7.44 $39,662 - $82,427	11,079 New	11,079 $82,000
Q2 2020 Aug 14, 2020	BUY	$3.58 - $7.44 $39,662 - $82,427	11,079 New	11,079 $82,000
Q4 2018 Feb 14, 2019	SELL	$5.84 - $11.92 $7,340 - $14,983	-1,257 Closed	0 $0
Q3 2018 Jul 13, 2023	BUY	$12.43 - $29.76 $71,360 - $170,852	5,741 New	5,741 $71.4 Million
Q3 2018 Nov 14, 2018	BUY	$12.43 - $29.76 $15,624 - $37,408	1,257 New	1,257 $16,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $532M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.